Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Applications of Site-Specific Labeling to Study HAMLET, a Tumoricidal Complex of alpha-Lactalbumin and Oleic Acid
  2. Mercer, N.; Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K.
  3. Plos One. 2011, Oct; 6(10): 12.
  1. 2.   STAT1 activation regulates proliferation and differentiation of renal progenitors
  2. Wang, H.; Yang, Y.; Sharma, N.; Tarasova, N. I.; Timofeeva, O. A.; Winkler-Pickett, R. T.; Tanigawa, S.; Perantoni, A. O.
  3. Cellular Signalling. 2010, Nov; 22(11): 1717-1726.
  1. 3.   RSK-Mediated Phosphorylation in the C/EBP beta Leucine Zipper Regulates DNA Binding, Dimerization, and Growth Arrest Activity
  2. Lee, S.; Shuman, J. D.; Guszczynski, T.; Sakchaisri, K.; Sebastian, T.; Copeland, T. D.; Miller, M.; Cohen, M. S.; Taunton, J.; Smart, R. C.; Xiao, Z.; Yu, L. R.; Veenstra, T. D.; Johnson, P. F.
  3. Molecular and Cellular Biology. 2010, Jun; 30(11): 2621-2635.
  1. 4.   Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel
  2. Stuelten, C. H.; Mertins, S. D.; Busch, J. I.; Gowens, M.; Scudiero, D. A.; Burkett, M. W.; Hite, K. M.; Alley, M.; Hollingshead, M.; Shoemaker, R. H.; Niederhuber, J. E.
  3. Stem Cells. 2010, Apr; 28(4): 649-660.
  1. 5.   Epigenetic gene regulation in stem cells and correlation to cancer
  2. Mathews, L. A.; Crea, F.; Farrar, W. L.
  3. Differentiation. 2009, Jul; 78(1): 1-17.
  1. 6.   Generation of a reporter-null allele of Ppap2b/Lpp3 and its expression during embryogenesis
  2. Escalante-Alcalde, D.; Morales, S. L.; Stewart, C. L.
  3. International Journal of Developmental Biology. 2009 53(1): 139-147.
  1. 7.   IKK alpha is required to maintain skin homeostasis and prevent skin cancer
  2. Liu, B. G.; Xia, X. J.; Zhu, F.; Park, E.; Carbajal, S.; Kiguchi, K.; DiGiovanni, J.; Fischer, S. M.; Hu, Y. L.
  3. Cancer Cell. 2008 14(3): 212-225.
  1. 8.   Caspase-dependent cleavage disrupts the ERK cascade scaffolding function of KSR1
  2. McKay, M. M.; Morrison, D. K.
  3. Journal of Biological Chemistry. 2007, Sep; 282(36): 26225-26234.
  1. 9.   Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model
  2. Tang, B.; Yoo, N.; Vu, M.; Mamura, M.; Nam, J. S.; Ooshima, A.; Du, Z.; Desprez, P. Y.; Anver, M. R.; Michalowska, A. M.; Shih, J.; Parks, W. T.; Wakefield, L. M.
  3. Cancer Research. 2007, Sep; 67(18): 8643-8652.
  1. 10.   Stop and go - Anti-proliferative and mitogenic functions of the transcription factor C/EBP beta
  2. Sebastian, T.; Johnson, P. F.
  3. Cell Cycle. 2006, May; 5(9): 953-957.
  1. 11.   C/EBP beta is a critical mediator of steroid hormone-regulated cell proliferation and differentiation in the uterine epithelium and stroma
  2. Mantena, S. R.; Kannan, A.; Cheon, Y. P.; Li, Q. X.; Johnson, P. F.; Bagchi, I. C.; Bagchi, M. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, FEB 7; 103(6): 1870-1875.
  1. 12.   Absolute oxygen tension (pO(2)) muscle tissue as determined by in murine fatty and EPR
  2. Matsumoto, A.; Matsumoto, S.; Sowers, A. L.; Koscielniak, J. W.; Trigg, N. J.; Kuppusamy, P.; Mitchell, J. B.; Subramanian, S.; Krishna, M. C.; Matsumoto, K.
  3. Magnetic Resonance in Medicine. 2005, DEC; 54(6): 1530-1535.
  1. 13.   C/EBP delta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution
  2. Thangaraju, M.; Rudelius, M.; Bierie, B.; Raffeld, M.; Sharan, S.; Hennighausen, L.; Huang, A. M.; Sterneck, E.
  3. Development. 2005, NOV; 132(21): 4675-4685.
  1. 14.   Mammary development and tumorigenesis in mice expressing a truncated human Notch4/Int3 intracellular domain (h-Int3sh)
  2. Raafat, A.; Bargo, S.; Anver, M. R.; Callahan, R.
  3. Oncogene. 2004, DEC 16; 23(58): 9401-9407.
  1. 15.   Transcription factor blockade for mammary gland biology and prevention of breast cancer
  2. Shen, Q.; Zhang, Y.; Hill, J.; Lu, C. H.; Kim, H. T.; Chodosh, L. A.; Young, M.; Colburn, N.; Brown, P. H.
  3. Cancer Epidemiology Biomarkers & Prevention. 2004, NOV; 13(11, Part 2): 1920S-1920S.
  1. 16.   Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK
  2. Zhao, L.; Hart, S.; Cheng, J. G.; Melenhorst, J. J.; Bierie, B.; Ernst, M.; Stewart, C.; Schaper, F.; Heinrich, P. C.; Ullrich, A.; Robinson, G. W.; Hennighausen, L.
  3. Journal of Biological Chemistry. 2004, OCT 15; 279(42): 44093-44100.
  1. 17.   Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis
  2. Chu, E. Y.; Hens, J.; Andl, T.; Kairo, A.; Yamaguchi, T. P.; Brisken, C.; Glick, A.; Wysolmerski, J. J.; Millar, S. E.
  3. Development. 2004, OCT; 131(19): 4819-4829.
  1. 18.   Quantitative three-dimensional microscopy approaches with applications in breast cancer biology including measurement of genomic instability
  2. Lockett, S.; de Solorzano, C. O.; Baggett, D.; Chin, K.
  3. Journal of Mammary Gland Biology and Neoplasia. 2004, OCT; 9(4): 383-391.
  1. 19.   Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability
  2. Huang, A. M.; Montagna, C.; Sharan, S.; Ni, Y. J.; Ried, T.; Sterneck, E.
  3. Oncogene. 2004 23(8): 1549-1557.
  1. 20.   Comparison of mammary gland involution between 129S1 and C57BL/6 inbred mouse strains: differential regulation of Bcl2a1, Trp53, Cebpb, and Cebpd expression
  2. Thangaraju, M.; Sharan, S.; Sterneck, E.
  3. Oncogene. 2004 23(14): 2548-2553.
  1. 21.   Radiation quality and tissue-specific microenvironments following exposure to 1 GeV/amu Fe
  2. Costes, S.; Barcellos-Hoff, M. H.
  3. Space Life Sciences: Biological Research and Space Radiation. 2002; 30, Issue 4 : 865-870.
  1. 22.   Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects
  2. Yang, Y. A.; Dukhanina, O.; Tang, B. W.; Mamura, M.; Letterio, J. J.; MacGregor, J.; Patel, S. C.; Khozin, S.; Liu, Z. Y.; Green, J.; Anver, M. R.; Merlino, G.; Wakefield, L. M.
  3. Journal of Clinical Investigation. 2002 109(12): 1607-1615.
  1. 23.   CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling
  2. Zhu, S. Y.; Yoon, K.; Sterneck, E.; Johnson, P. F.; Smart, R. C.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2002 99(1): 207-212.
  1. 24.   Generation of truncated C/EBP beta isoforms by in vitro proteolysis
  2. Baer, M.; Johnson, P. F.
  3. Journal of Biological Chemistry. 2000 275(34): 26582-26590.
  1. 25.   Alteration of Met protooncogene product expression and prognosis in breast carcinomas
  2. Tsarfaty, I.; Alvord, W. G.; Resau, J. H.; Altstock, R. T.; Lidereau, R.; Bieche, I.; Bertr, F.; Horev, J.; Klabansky, R. L.; Keydar, I.; Vande Woude, G. F.
  3. Analytical and Quantitative Cytology and Histology. 1999 21(5): 397-408.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel